Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cholinergic-specific glycoconjugates

V P Whittaker1, S Kelić

  • 1Max-Planck-Institut für Biophysikalische Chemie, Göttingen, FR Germany.

Neurochemical Research
|November 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparative studies on synaptosomes: Applicability of the rapid method for preparing synaptosomes to elasmobranch brain.

Neurochemical research·2013
Same author

The historical significance of work with electric organs for the study of cholinergic transmission.

Neurochemistry international·2010
Same author

British anti-lewisite; antidotal effects against therapeutic arsenicals.

The Biochemical journal·2010
Same author

CD81 regulates neuron-induced astrocyte cell-cycle exit.

Molecular and cellular neurosciences·2001
Same author

Arcachon and cholinergic transmission.

Journal of physiology, Paris·1998
Same author

Interferon-gamma alters nerve-induced redistribution of acetylcholine receptors in cultured rat skeletal muscle cells.

Brain research bulletin·1997
Same journal

Correction to: Dual Antioxidant DH-217 Mitigated Cerebral Ischemia-Reperfusion Injury by Targeting IKKβ/Nrf2/HO-1 Signal Axis.

Neurochemical research·2026
Same journal

Microglia-Dependent BDNF Signaling in the Dentate Gyrus Underlies the Antidepressant Effects of Gardiquimod, a Toll-Like Receptor 7 Agonist, in Chronically Stressed Mice.

Neurochemical research·2026
Same journal

Cryptotanshinone Targets Ferroptosis in Glioma via the EGFR/ROS Signaling Pathway.

Neurochemical research·2026
Same journal

Combined Puerarin and Magnesium Acetyl Taurate Intervention Mitigates Autism-Like Pathology Through Glutamatergic and MAPK Pathway Regulation.

Neurochemical research·2026
Same journal

Long-Term Impact of Early-Life Stress on Hippocampal Apoptotic Gene Expression in BALB/c Mice.

Neurochemical research·2026
Same journal

Minute-Resolution Sampling Reveals Rapid and Stimulus-Specific IL-1β Dynamics During Acute Epileptiform Activity.

Neurochemical research·2026
See all related articles

Cholinergic nerve terminals use glycoconjugates as surface markers and within synaptic vesicles. Researchers identified novel gangliosides (Chol-1) and a protein antigen (Chol-2) on cholinergic terminals.

Area of Science:

  • Neuroscience
  • Biochemistry

Background:

  • Cholinergic nerve terminals employ glycoconjugates for surface marking and synaptic vesicle structure.
  • Synaptic vesicle glycoconjugates play roles in acetylcholine sequestration and membrane stability.

Purpose of the Study:

  • To identify and characterize glycoconjugates serving as surface markers on cholinergic nerve terminals.
  • To investigate the structural and functional roles of glycoconjugates within cholinergic synaptic vesicles.

Main Methods:

  • Immunochemical identification of surface antigens using antibodies.
  • Characterization of novel gangliosides (Chol-1) and protein antigens (Chol-2).
  • Analysis of proteoglycans within cholinergic synaptic vesicles.

Main Results:

Related Experiment Videos

  • Discovery of Chol-1, a series of minor gangliosides with a sialylated N-acetylgalactosamine residue, potentially major at cholinergic terminals.
  • Identification of Chol-2, a protein antigen sharing an epitope with a Torpedo electric organ ganglioside.
  • Cholinergic synaptic vesicles are rich in a proteoglycan involved in acetylcholine sequestration and membrane stabilization.

Conclusions:

  • Glycoconjugates are crucial for cholinergic terminal function, acting as specific surface markers and structural components of synaptic vesicles.
  • The identified antigens (Chol-1 and Chol-2) provide molecular targets for studying cholinergic subpopulations.
  • The synaptic vesicle proteoglycan may be the cholinergic equivalent of chromogranins, essential for vesicle integrity and neurotransmitter handling.